Companies
Maxim Group slashes price target on Bioline Rx Ltd ADR [BLRX] – find out why.
Bioline Rx Ltd ADR [NASDAQ: BLRX] price plunged by -40.71 percent to reach at -$0.23. The one-year BLRX stock forecast points to a potential upside of 96.74. The average equity rating for BLRX stock is currently 1.00, trading closer to a bullish pattern in the
